(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 27.5% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Glaukos's revenue in 2025 is $383,481,000.On average, 8 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,205,235,786, with the lowest GKOS revenue forecast at $27,092,383,851, and the highest GKOS revenue forecast at $27,384,271,563. On average, 8 Wall Street analysts forecast GKOS's revenue for 2026 to be $34,994,451,703, with the lowest GKOS revenue forecast at $33,825,147,267, and the highest GKOS revenue forecast at $37,232,653,465.
In 2027, GKOS is forecast to generate $43,618,149,699 in revenue, with the lowest revenue forecast at $40,983,071,157 and the highest revenue forecast at $49,226,070,645.